Arkolith/Insider Trading/INBX/Form 4

Forsyth Douglas

DirectorInhibrx Biosciences, Inc. (INBX) · full profile →Form 4 · filed Aug 26, 2024
Net Buying
Open-Market Buys
$1.0M
Open-Market Sells
$0
Net Open-Market Flow
$1.0M
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 23, 2024Buy(P)60K$14.07$842K225K
Aug 22, 2024Buy(P)15K$12.89$196K165K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0002007919-24-000040) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML